SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Buyers of Regeneron Prescription drugs By Investing.com
Faruqi & Faruqi, LLP Securities Litigation Accomplice James (Josh) Wilson Encourages Buyers…
Bennett C. Frank of Ionis Prescription drugs sells $222,113 in inventory By Investing.com
Bennett C. Frank, Govt Vice President and Chief Scientific Officer at Ionis…
Ironwood Prescribed drugs shares surge on competitor’s woes By Investing.com
Investing.com -- Shares of Ironwood Prescribed drugs (NASDAQ:) soared by as a…
EyePoint Prescribed drugs Experiences Inducement Grants Beneath NASDAQ Itemizing Rule 5635(c)(4) By Investing.com
WATERTOWN, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- EyePoint Prescribed drugs, Inc.…
Ars Prescribed drugs’ chief enterprise officer sells $1.77m in inventory By Investing.com
SAN DIEGO—Justin Chakma, the Chief Business Officer of ARS Prescribed drugs, Inc.…
60 Levels Prescribed drugs launches babesiosis drug trial By Investing.com
WASHINGTON - 60 Levels Prescribed drugs Inc. (NASDAQ: SXTP; SXTPW), an organization…
Ars Prescribed drugs director Laura Shawver sells shares for $2.69 million By Investing.com
Laura Shawver, a director at ARS Prescribed drugs, Inc. (NASDAQ:SPRY), has reported…
Lexicon Prescribed drugs inventory hits 52-week low at $0.73 By Investing.com
In a difficult yr for Lexicon Prescribed drugs (NASDAQ:) Inc., the corporate's…
Catalyst Prescribed drugs chief compliance officer sells $286,703 in inventory By Investing.com
CORAL GABLES, FL—Brian Elsbernd, the Chief Compliance and Authorized Officer of Catalyst…
Corvus Prescribed drugs Proclaims New Information Highlighting Potential of Ciforadenant to Overcome Immunotherapy Resistance in Metastatic Castration Resistant Prostate Most cancers By Investing.com
BURLINGAME, Calif., Nov. 09, 2024 (GLOBE NEWSWIRE) -- Corvus Prescribed drugs, Inc.…
